Loading...
Loading...
Loading...
Loading...
MBL Life Sciences

| Product Specifications | |
| Application | FC |
| Reactivity | Mouse |
| Conjugation | PE |
| Immunogen | TRP2 (mouse) |
| Peptide Sequence | SVYDFFVWL |
| Class | Class I |
| Sequence Location | 180-188 |
| MHC Allele | H-2Kb |
| Documents & Links for H-2Kb TRP-2 Tetramer-SVYDFFVWL-PE | |
| Datasheet | H-2Kb TRP-2 Tetramer-SVYDFFVWL-PE Datasheet |
| Documents & Links for H-2Kb TRP-2 Tetramer-SVYDFFVWL-PE | |
| Datasheet | H-2Kb TRP-2 Tetramer-SVYDFFVWL-PE Datasheet |
| Citations for H-2Kb TRP-2 Tetramer-SVYDFFVWL-PE – 4 Found |
| Mu, Li-Min; Liu, Lei; Liu, Rui; Du, Ya-Fei; Luo, Qian; Xu, Jia-Rui; Xie, Ying; Lu, Wan-Liang. Nanostructured SL9-CpG Lipovaccines Elicit Immune Response for the Treatment of Melanoma. International Journal Of Molecular Sciences. 2019;20(9) PubMed |
| Kuwada, Eri; Kambara, Kaori; Tadaki, Toshimasa; Noguchi, Katsuo. Insoluble fraction of tumor cell homogenate is a useful material for eliciting cytotoxic T lymphocytes: a unique method for protein solubilization. Anticancer Research. 2011;31(3):881-91. PubMed |
| Okano, Fumiyoshi; Merad, Miriam; Furumoto, Katsuyoshi; Engleman, Edgar G. In vivo manipulation of dendritic cells overcomes tolerance to unmodified tumor-associated self antigens and induces potent antitumor immunity. Journal Of Immunology (Baltimore, Md. : 1950). 2005;174(5):2645-52. PubMed |
| Takeshima, Tsuguhide; Chamoto, Kenji; Wakita, Daiko; Ohkuri, Takayuki; Togashi, Yuji; Shirato, Hiroki; Kitamura, Hidemitsu; Nishimura, Takashi. Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. Cancer Research. 2010;70(7):2697-706. PubMed |
No reviews have been added for this product.
MBL Life Sciences


| Product Specifications | |
| Application | FC |
| Reactivity | Mouse |
| Conjugation | PE |
| Immunogen | TRP2 (mouse) |
| Peptide Sequence | SVYDFFVWL |
| Class | Class I |
| Sequence Location | 180-188 |
| MHC Allele | H-2Kb |
| Documents & Links for H-2Kb TRP-2 Tetramer-SVYDFFVWL-PE | |
| Datasheet | H-2Kb TRP-2 Tetramer-SVYDFFVWL-PE Datasheet |
| Documents & Links for H-2Kb TRP-2 Tetramer-SVYDFFVWL-PE | |
| Datasheet | H-2Kb TRP-2 Tetramer-SVYDFFVWL-PE Datasheet |
| Citations for H-2Kb TRP-2 Tetramer-SVYDFFVWL-PE – 4 Found |
| Mu, Li-Min; Liu, Lei; Liu, Rui; Du, Ya-Fei; Luo, Qian; Xu, Jia-Rui; Xie, Ying; Lu, Wan-Liang. Nanostructured SL9-CpG Lipovaccines Elicit Immune Response for the Treatment of Melanoma. International Journal Of Molecular Sciences. 2019;20(9) PubMed |
| Kuwada, Eri; Kambara, Kaori; Tadaki, Toshimasa; Noguchi, Katsuo. Insoluble fraction of tumor cell homogenate is a useful material for eliciting cytotoxic T lymphocytes: a unique method for protein solubilization. Anticancer Research. 2011;31(3):881-91. PubMed |
| Okano, Fumiyoshi; Merad, Miriam; Furumoto, Katsuyoshi; Engleman, Edgar G. In vivo manipulation of dendritic cells overcomes tolerance to unmodified tumor-associated self antigens and induces potent antitumor immunity. Journal Of Immunology (Baltimore, Md. : 1950). 2005;174(5):2645-52. PubMed |
| Takeshima, Tsuguhide; Chamoto, Kenji; Wakita, Daiko; Ohkuri, Takayuki; Togashi, Yuji; Shirato, Hiroki; Kitamura, Hidemitsu; Nishimura, Takashi. Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. Cancer Research. 2010;70(7):2697-706. PubMed |